Porcine PD-L1: cloning, characterization, and implications during xenotransplantation

被引:24
|
作者
Jeon, Dae-Hyun
Oh, Keunhee
Oh, Byoung C.
Nam, Dong H.
Kim, Chi H.
Park, Hyung-Bae
Cho, Jaejin
Lee, Jeong R.
Lee, Dong-Sup
Lee, Gene
机构
[1] Seoul Natl Univ, Lab Mol Genet & Stem Cell Differentiat, Seoul 110799, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Lab Immunol, Seoul 110799, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
关键词
cell proliferation; human PD-1; human T cells; porcine PD-L1; xenotransplantation;
D O I
10.1111/j.1399-3089.2007.00403.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Effective intervention achieved by manipulating cell-mediated xenogeneic immune responses would critically increase the clinical feasibility of xenotransplantation as immediate hyperacute rejections become controllable through genetic modulations of donor organs. Endogenous negative regulatory signals like the programmed death 1 (PD-1)-programmed death ligand 1 (PD-L1) system are candidate targets for the control of cell-mediated xenogeneic immune response. Methods: A porcine PD-L1 molecule was cloned using RACE (rapid amplification of cDNA ends) technology based on the human PD-L1 sequence. The functional effects of cloned porcine PD-L1 were tested on human CD4(+) T cell activation using porcine PD-L1-transfected bystander cells. Cellular proliferation was monitored by [H-3] thymidine incorporation, and human T cell apoptosis was measured by flow cytometry. Results: Porcine PD-L1 (GenBank accession number AY837780) was found to have 73.8% sequence homology with human PD-L1 and to contain two immunoglobulin domains in its extracellular region. Moreover, porcine PD-L1 expressed on Chinese hamster ovary (CHO) cells inhibited human CD4(+) T cell proliferation stimulated with anti-CD3 only or anti-CD3 plus anti-CD28. Percentages of apoptotic activated human T cells increased by over 30% in the presence of porcine PD-L1/CHO cells, and the addition of recombinant human PD-1-Fc fusion proteins during human T cell activation reversed the inhibitory effects of porcine PD-L1. Conclusions: Cloned porcine PD-L1 showed high sequence homology with human PD-L1 and a similar molecular structure. Moreover, porcine PD-L1 inhibited human CD4(+) T cell activation in human PD-1-dependent manner, and this involved activated T cell apoptosis. The authors suggest that PD-1-PD-L1 might play an important endogenous immune regulatory role during xenogeneic transplantation, and that the effective application of this system would improve transplanted xenogeneic organ survival.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [31] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Laurence P. Diggs
    Eddy C. Hsueh
    Biomarker Research, 5
  • [32] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [33] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    BIOMARKER RESEARCH, 2017, 5
  • [34] Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy
    Ju, Xiaoli
    Zhang, Heng
    Zhou, Zidi
    Wang, Qiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (01): : 1 - 11
  • [35] In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
    Lu, Chih-Hao
    Chung, Wei-Min
    Tsai, Chun-Hao
    Cheng, Ju-Chien
    Hsu, Kai-Cheng
    Tzeng, Huey-En
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas
    Vimalathas, Gayaththri
    Kristensen, Bjarne Winther
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (01)
  • [37] PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay
    Cimadamore, Alessia
    Massari, Francesco
    Santoni, Matteo
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Montironi, Rodolfo
    Moch, Holger
    CURRENT DRUG TARGETS, 2020, 21 (16) : 1664 - 1671
  • [38] In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
    Chih-Hao Lu
    Wei-Min Chung
    Chun-Hao Tsai
    Ju-Chien Cheng
    Kai-Cheng Hsu
    Huey-En Tzeng
    Scientific Reports, 12
  • [39] Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1
    Jiang, Mengzhen
    Liu, Man
    Liu, Guodi
    Ma, Jiawen
    Zhang, Lixin
    Wang, Shenlin
    MABS, 2023, 15 (01)
  • [40] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161